Lv5
1552 积分 2021-12-10 加入
PD-1, BTLA and TIGIT as therapeutic targets for rheumatic disease
17天前
已完结
Therapeutic treatment with PD-1 agonist antibody prevents progressive autoantibody increase in murine autoimmune disease models 2258756
17天前
已完结
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
23天前
已完结
Precision engineering of antibodies: A review of modification and design in the Fab region
1个月前
已完结
Deciphering the role of cytokines in aging: Biomarker potential and effective targeting
1个月前
已完结
Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells
1个月前
已完结
Agonistic anti-PD-1 antibodies downregulate autoantibody development in lupus model mice
2个月前
已关闭
Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders
2个月前
已完结
Agonistic anti-PD-1 antibodies downregulate autoantibody development in lupus model mice
2个月前
已完结
Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection
4个月前
已完结
皖公网安备34019202002308
